Medsi Clinic #1, Moscow Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2020
NCT04380376
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Medsi Clinic #1, Moscow | MEDSI Clinical Hospital 1

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Respiratory Aspiration (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 7